Zyla Health receives fresh funding of $1 million in its Pre-Series A round
- ByStartupStory | July 6, 2022
Zyla Health, a platform for managing personalised care, wants to transform the way healthcare is delivered in India. To speed up its expansion, it has secured $1 million in new capital as part of a pre-series round. Investment firm, SuperMorpheus along with other investors including, Oyo Chief Growth Officer Kavikrut, Epigamia Co-founder & COO Rahul Jain, Epigamia Co-founder & Director Uday Thakker and Haitong Securities Managing Director, Investment Banking Vivek Shah, also took part in the round, said the company in a statement.
Zyla provides individualised treatment for a variety of medical, physical, and emotional health requirements. A thorough evaluation of the population’s health risks precedes the individualised care journeys, which might range from chronic illness treatment to wellness initiatives.
Prior to this fundraising, Kae Funds and Secocha Ventures, two reputable institutional investors, provided capital to Zyla. With the most recent round of funding, the firm hopes to grow by a factor of five this year.
Khushboo Aggarwal, founder and CEO of Zyla said, “Insurers and employers are making investments in the health of their members and teams through Zyla’s data-driven, highly-utilized solutions, and we have seen significant traction in our B2B2C model over the past several quarters. We are still working to provide patients with the best possible healthcare outcomes. The funds will be used to bolster the organization’s leadership and invest in integrating Zyla’s care offering across the ecosystem for development.”
Follow Startup Story
Related Posts
